Growing Japanese Generics Market Gaining Pharma Firms’ Increased Attention

FOR IMMEDIATE RELEASE
NOIDA, U.P, India, Republic of (Free-Press-Release.com) February 25, 2012 --

With a view to reducing burgeoning healthcare costs and tackling rising cases of life-threatening diseases, the Japanese government is taking various measures to increase the adoption of generic drugs among people in the country. As per the findings of a latest research report by RNCOS, the Japanese generic drugs market, evolving to become the world’s next generic hub, offers a wide range of opportunities to both domestic and international players. The patent expiry of a large number of branded drugs and active pharmaceutical ingredients are the major attractions for companies willing to enter the market.

According to “Japan Generics Market Analysis”, the pharmaceutical market in Japan has been growing effectively for the past few years, and the generic drugs sector holds an immense growth potential due to increasing healthcare costs. It is expected that the strong government support, incentives, developments and promising factors will boost the generics industry’s revenue in near future, and the market will advance at a CAGR of around 9% during 2012-2014.

Circulatory system disorders and cancers account for the majority of healthcare expenditures in the country. The comprehensive 50-page report foresees that neurological diseases and cancer will be the focus area for the Japanese generic drugs manufacturers in near future.

The report provides an in-depth research and rational analysis of the current status and expected position of the Japanese generics market. It facilitates forecasts on overall pharmaceutical industry size and generics market for the period 2012-2014. The research evaluates and analyzes the opportunities for generics companies in Japan in terms of patent expiries and therapeutic areas to be tapped. Regulatory environment’s overview and recent industry developments have also been included in the study to present a balanced outlook of the Japanese generic drugs market to clients.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM371.htm

Some of our Related Reports are:

- Generic Drug Market in Canada (http://www.rncos.com/Report/IM598.htm)
- Cancer Generics Market Analysis (http://www.rncos.com/Report/IM353.htm)
- Booming Generics Drug Market in India (http://www.rncos.com/Report/IM256.htm)
- UK Generics Market Analysis (http://www.rncos.com/Report/IM313.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

Japan DPC Hospitals     Japan Generics Market     Japan Pharmaceutical Market